Ultragenyx Pharmaceutical Inc. (RARE): Cash & Equivalents
$421.00M
As of 2025-12-31
$125.00M
As of 2026-06-30
+46.8%
3-year compound annual growth
-10.0%
5-year compound annual growth
+16.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $421.00M | +142.0% | 2026-02-18, Balance as of period end |
| 2024-12-31 | $174.00M | -18.7% | 2026-02-18, Balance as of period end |
| 2023-12-31 | $214.00M | +61.0% | 2026-02-18, Balance as of period end |
| 2022-12-31 | $132.94M | -56.8% | 2025-02-19, Balance as of period end |
| 2021-12-31 | $307.58M | -56.9% | 2024-02-21, Balance as of period end |
| 2020-12-31 | $713.53M | +64.6% | 2023-02-17, Balance as of period end |
| 2019-12-31 | $433.58M | +282.2% | 2022-02-15, Balance as of period end |
| 2018-12-31 | $113.43M | +12.9% | 2021-02-12, Balance as of period end |
| 2017-12-31 | $100.49M | -37.6% | 2020-02-14, Balance as of period end |
| 2016-12-31 | $161.12M | +72.2% | 2019-02-20, Balance as of period end |
| 2015-12-31 | $93.57M | +284.7% | 2018-02-21, Balance as of period end |
| 2014-12-31 | $24.32M | +227.5% | 2017-02-17, Balance as of period end |
| 2013-12-31 | $7.43M | -91.4% | 2016-02-26, Balance as of period end |
| 2012-12-31 | $86.19M | n/a | 2015-03-27, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $421.00M | +142.0% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $165.60M | -9.8% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $322.93M | +2.4% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $128.45M | +85.3% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $170.18M | +12.2% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $158.54M | -42.7% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $79.15M | -56.0% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $205.40M | +106.4% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $364.41M | -14.6% |
Compare RARE, KNSA, AXSM, SUPN side by side · Screen every company in Pharmaceutical Preparations ↗